Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
---|
10/05/2011 | EP2370581A2 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf |
10/05/2011 | EP2370580A2 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1 |
10/05/2011 | EP2370082A1 Drug composition cytotoxic for pancreatic cancer cells |
10/05/2011 | CN102206240A Process for the synthesis of azacitidine and decitabine |
10/05/2011 | CN102206239A Preparation method of capecitabine |
10/05/2011 | CN101061131B Gemcitabine derivatives nanoparticles |
10/04/2011 | US8030471 Plasmodium malariae and Plasmodium ovale genes and uses thereof |
10/04/2011 | US8030096 Water-soluble rhodamine dyes conjugates |
09/29/2011 | WO2011119969A1 Method of reducing intraocular pressure in humans using n6 -cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof |
09/29/2011 | WO2011119919A1 Adenosine compounds and their use thereof |
09/29/2011 | WO2011119674A1 Methods and compositions related to modified adenosines for controlling off-target effects in rna interference |
09/29/2011 | WO2011002200A3 Novel guanosine-rich modified oligonucleotides and antiproliferative activity thereof |
09/29/2011 | US20110237787 High throughput nucleic acid sequencing by expansion |
09/29/2011 | US20110237531 Method for producing sophorose lipid |
09/29/2011 | US20110237529 Adenosine Analogs and Their Use |
09/29/2011 | US20110236463 Formulations for systemic buccal delivery comprising s-adenosylmethionine, their preparation and use |
09/29/2011 | CA2792266A1 Method of reducing intraocular pressure in humans using n6-cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof |
09/29/2011 | CA2792265A1 Adenosine compounds and their use thereof |
09/28/2011 | EP2367837A2 1'-substituted ribose 5'-polyphosphate analogs and their use as modulators of p2y receptor activity |
09/28/2011 | CN102203111A Enantiomeric resolution of 2,4-disubstituted 1,3-oxathiolane nucleosides |
09/28/2011 | CN102199183A C-di-GMP, analogues thereof and preparation method thereof |
09/28/2011 | CN102199182A One-step extraction method for disodium 5'-inosinate |
09/28/2011 | CN102199181A Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives |
09/28/2011 | CN102199180A Preparation method of capectabine |
09/27/2011 | US8026356 Process for the large scale production of Stavudine |
09/27/2011 | US8026348 Nucleoside derivative, modified oligonucleotide, method for their synthesis and applications thereof |
09/27/2011 | US8026057 Nucleic acid labeling compounds |
09/27/2011 | CA2493815C Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations |
09/27/2011 | CA2425112C Massive parallel method for decoding dna and rna |
09/22/2011 | WO2011115818A1 5'-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom |
09/22/2011 | WO2011115817A1 Methods of preparing 2'-o-substituted purine nucleosides |
09/22/2011 | WO2011115513A2 A cytosine analogue, a method of preparation of a cytosine analogue, a dna methyltransferase 1 inhibitor, a method for dna methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal dna methylation |
09/22/2011 | WO2011113175A1 Cytarabine prodrug derivatives and use for resisting cancer or tumor thereof |
09/22/2011 | WO2011113174A1 Cytarabine derivatives and uses for anticancer and antitumor thereof |
09/22/2011 | WO2011113173A1 Cytarabine prodrug derivatives and use for resisting cancer or tumor thereof |
09/22/2011 | US20110230436 Uracyl Cyclopropyl Nucleotides |
09/22/2011 | US20110230435 Methods and Compositions for Treating Obesity and Related Disorders |
09/22/2011 | US20110229918 Method of Quantifying Transient Interactions Between Proteins |
09/22/2011 | US20110226610 Synthesis of nitrodibenzylfuran chromophore for photodeprotection of organic molecules |
09/21/2011 | EP2045258B1 3'-ethynylcytidine derivative |
09/21/2011 | CN102190695A Preparation method for 5'-deoxy-2',3'-diacetyl-5-fluorocytidine |
09/20/2011 | US8022194 2′-nitrobenzyl-modified ribonucleotides |
09/20/2011 | US8022193 6-modified bicyclic nucleic acid analogs |
09/20/2011 | US8021839 Quantitative analysis; optical properties; kits |
09/20/2011 | CA2676115C Nucleotide with an alpha-phosphate mimetic |
09/20/2011 | CA2506532C Anhydrous crystalline azido cytosine hemisulfate derivative |
09/20/2011 | CA2468552C 3-.beta.-d-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof |
09/15/2011 | WO2011112947A1 Methods and compositions comprising nucleic acid polymerization enhancers |
09/15/2011 | WO2011111501A1 Rna containing nucleoside compound, method for controlling amount of protein production from that rna and nucleoside compound |
09/15/2011 | US20110224422 Preparation of capecitabine |
09/15/2011 | US20110224421 Preparation of intermediates useful in the synthesis of 2'-cyano-2'-deoxy-n4-palmi-toyl-1-beta-d-arabinofuranosylcytosine |
09/15/2011 | US20110224099 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
09/15/2011 | US20110223677 Carboxamide-substituted dyes for analytical applications |
09/14/2011 | EP2364989A1 Stable NAD/NADH-derivatives |
09/14/2011 | EP2364988A1 Stable NAD/NADH derivatives |
09/14/2011 | CN102186872A Anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculous agent |
09/14/2011 | CN102180944A Remodeling and glycoconjugation of peptides |
09/14/2011 | CN102180926A Monomers of 3'thio-hypoxanthine deoxyribonucleoside phosphoramidite and application thereof |
09/14/2011 | CN102180925A Method for treating emulsion layer in process for synthesizing 5-methyluridine |
09/14/2011 | CN102180924A L-ribo-LNA analogues |
09/14/2011 | CN102180923A Method for stereoselective preparation of derivatives of pyrane |
09/14/2011 | CN101497640B Novel crystal form of clofarabine |
09/13/2011 | CA2378187C Methods for treating therapy-resistant tumors |
09/09/2011 | WO2011108682A1 Ribonucleoside phosphorothioate manufacturing method |
09/08/2011 | US20110218114 Nucleotide triphosphate with an electroactive label conjugated to the gamma phosphate |
09/07/2011 | EP2362811A2 Apparatus and method using rotary flow distribution mechanisms |
09/07/2011 | CN102177172A Compounds and pharmaceutical compositions for the treatment of viral infections |
09/07/2011 | CN102174038A Anti-viral nucleoside for treating viral infections |
09/06/2011 | US8013147 Heterocyclic compounds and their use in the detection of nucleic acids |
09/01/2011 | WO2011104540A1 One step process for the preparation of capecitabine |
09/01/2011 | WO2011051733A3 Derivatives of uridine phosphate and their uses in protein binding assays |
09/01/2011 | US20110212437 Single molecule sequencing with two distinct chemistry steps |
09/01/2011 | US20110212030 Nucleic Acid Ligand Complexes |
08/31/2011 | EP2361922A1 Intermediate to HCV-Nucleoside Inhibitors |
08/31/2011 | EP2361921A2 Novel bicyclonucleoside and oligonnucleotide analogue |
08/31/2011 | EP2361256A1 Cyclohexenyl nucleic acid analogs |
08/31/2011 | CN102171233A Process for preparing azacytidine intermediate |
08/31/2011 | CN102171195A Synthesis of decitabine |
08/31/2011 | CN102168123A Novel method for preparing deoxyribonucleoside triphosphate (dNMP) |
08/31/2011 | CN102167716A Synthesis method of clofarabine, midbody thereof and preparation method of midbody |
08/31/2011 | CN101676295B Method for purifying and separating 2'-deoxidized-2',2'-difluoro nucleotide |
08/31/2011 | CN101381387B Method for preparing 2'-deoxy-2',2'-difluoro-beta-cytidine hydrochlorate |
08/30/2011 | US8008308 Phosphonate compounds |
08/30/2011 | US8008274 P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating sinusitis |
08/30/2011 | US8008007 S-adenosyl-L-methionine analogs with extended activated groups for transfer by methyltransferases |
08/30/2011 | US8008005 Method for the synthesis of DNA sequences |
08/30/2011 | CA2610283C Process of making an alpha-anomer enriched 2-deoxy-2,2-diflouro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside |
08/30/2011 | CA2460911C 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof |
08/25/2011 | WO2011103468A2 Phosphoramidites for synthetic rna in the reverse direction |
08/25/2011 | CA2790483A1 Phosphoramidites for synthetic rna in the reverse direction |
08/24/2011 | EP2360166A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
08/24/2011 | CN201942628U 肌苷生产中过滤装置 Inosine production filtration device |
08/24/2011 | CN102164939A Antiviral nucleoside compounds |
08/24/2011 | CN102161686A Method for preparing doxifluridine |
08/23/2011 | US8003353 cyanocobalamin at 0.5%, citric acid 0.12%, sodium citrate 0.32%, glycerin 2.23%, benzalkonium chloride 0.02% and 96.79% water; elevating the vitamin B12 levels in the cerebral spinal fluid; intranasally spray |
08/23/2011 | US8003324 Modulation of sodium channels by nicotinamide adenine dinucleotide |
08/18/2011 | WO2011099443A1 Β-dihydrofuran deriving compound, method for producing β-dihydrofuran deriving compound or β-tetrahydrofuran deriving compound, β-glycoside compound, method for producing β-glycoside compound, and method for producing 4'-ethynyl d4t and analogue compounds thereof |
08/18/2011 | US20110201800 Azacitidine process and polymorphs |
08/18/2011 | US20110201674 Saporin-L1 inhibitors and uses thereof |
08/18/2011 | US20110200569 Increasing the shelf life of bakery and patisserie products by using the antifungal lactobacillus amylovorus dsm 19280 |